Average Co-Inventor Count = 23.20
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The United States of America, as Represented by the Secretary, Department of Health and Human Services (7 from 3,540 patents)
2. Hospital Clinic De Barcelona (7 from 21 patents)
3. British Columbia Cancer Agency Branch (6 from 65 patents)
4. Universität De Barcelona (6 from 47 patents)
5. Oslo University Hospital Hf (6 from 11 patents)
6. Julius-Maximilians-University of Wurzburg (6 from 6 patents)
7. The University of Arizona (5 from 975 patents)
8. University of Nebraska (5 from 937 patents)
9. Oregon Health & Science University (5 from 509 patents)
10. The Cleveland Clinic Foundation (3 from 1,041 patents)
11. University of Rochester (3 from 975 patents)
12. University of London (3 from 89 patents)
13. Mayo Foundation for Medical Education and Research (2 from 1,747 patents)
14. City of Hope (1 from 639 patents)
15. Julius-Maximilians-Universitaet Wuerzburg (17 patents)
7 patents:
1. 11725248 - Evaluation of mantle cell lymphoma and methods related thereto
2. 11646099 - Method for determining lymphoma type and providing treatment
3. 11574704 - Method for subtyping lymphoma types by means of expression profiling
4. 11028444 - Survival predictor for diffuse large B cell lymphoma
5. 10697975 - Methods for identifying, diagnosing, and predicting survival of lymphomas
6. 10607717 - Method for subtyping lymphoma types by means of expression profiling
7. 9970059 - Survival predictor for diffuse large B cell lymphoma